Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Edelman Joseph
Relationship:   Former 10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   42    
Direct Shares   630,171    

Indirect Shares

   332,164,708      
Direct Value   $1,466,262    

Indirect Value

   $2,852,575,947      
Total Shares   332,794,879      
Total Value   $2,854,042,209      


Aegerion Pharmaceuticals, Inc. $0 Nautilus Biotechnology, Inc $1,466,262 Aegerion Pharmaceuticals, Inc. $0 Nautilus Biotechnology, Inc $1,466,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    79   
    21    

     Stock price went up :
    50   
    11    
     Stock price went down :
    29   
    10    
   
     Gain/Loss Ratio :
   1.7   
   1.1   
     Percentage Gain/Loss :
   13.4%
 197.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2008-06-23 0 2008-06-23 6,387,546    Premium*  
            Synageva BioPharma Corp GEVA 10% Owner 0 2011-11-02 0    Premium*  
            Aegerion Pharmaceuticals, Inc. AEGR 10% Owner 2012-11-01 133,133 2012-11-29 2,595,293    Premium*  
            Acelrx Pharmaceuticals Inc ACRX 10% Owner 0 2017-06-19 4,533,728    Premium*  
            Amicus Therapeutics Inc FOLD 10% Owner 0 2018-10-03 20,724,424    Premium*  
            VBI Vaccines Inc VBIV 10% Owner 0 2014-07-25 2,610,356    Premium*  
            Aldeyra Therapeutics, Inc. ALDX 10% Owner 0 2024-04-05 9,275,851    Premium*  
            Aravive Inc ARAV 10% Owner 0 2017-09-22 2,099,563    Premium*  
            Kadmon Holdings, Llc KDMN 10% Owner 0 2019-11-18 14,636,334    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2017-09-29 0 2018-08-10 4,070,357    Premium*  
            Global Blood Therapeutics, Inc. GBT 10% Owner 2017-12-19 0 2017-12-19 4,889,066    Premium*  
            Corium International, Inc. CORI 10% Owner 2018-01-16 0 2018-10-12 2,724,686    Premium*  
            Albireo Pharma Inc ALBO 10% Owner 2018-01-25 0 2022-10-13 1,939,723    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 2018-01-30 0 2024-01-11 6,906,646    Premium*  
            La Jolla Pharmaceutical Co LJPC 10% Owner 2018-02-13 0 2019-01-08 2,253,376    Premium*  
            Motus Gi Holdings Inc MOTS 10% Owner 2018-02-16 0 2021-01-22 2,660,542    Premium*  
            Quotient Ltd QTNTQ 10% Owner 2018-05-22 0 2022-10-31 7,945,211    Premium*  
            Dova Pharmaceuticals, Inc. DOVA 10% Owner 2018-06-04 0 2019-11-12 0    Premium*  
            Meiragtx Holdings Plc MGTX 10% Owner 2018-06-08 0 2023-05-05 11,281,103    Premium*  
            Crinetics Pharmaceuticals, Inc. CRNX 10% Owner 2018-07-20 0 2022-04-18 5,321,032    Premium*  
            Agile Therapeutics Inc AGRX 10% Owner 2018-07-26 0 2021-10-13 21,654,485    Premium*  
            Verrica Pharmaceuticals Inc. VRCA 10% Owner 2018-06-19 0 2023-12-29 7,099,182    Premium*  
            Athenex, Inc. ATNX 10% Owner 2019-05-06 0 2020-09-14 13,532,467    Premium*  
            ADMA Biologics Inc ADMA 10% Owner 2019-05-21 0 2021-09-30 13,262,375    Premium*  
            Foamix Pharmaceuticals Ltd FOMX 10% Owner 0 2019-07-29 11,203,881    Premium*  
            Lyra Therapeutics, Inc. LYRA Director, 10% Owner 2020-05-05 0 2023-05-31 12,757,563    Premium*  
            VYNE Therapeutics Inc VYNE 10% Owner 2020-06-09 0 2021-08-16 4,935,057    Premium*  
            Leap Therapeutics, Inc. LPTX 10% Owner 2020-06-22 0 2020-06-22 8,476,496    Premium*  
            Athira Pharma, Inc. ATHA Director, 10% Owner 0 2023-12-29 5,402,964    Premium*  
            Cerevel Therapeutics Holdings, I... CERE Director 2020-10-20 0 2024-02-20 10,794,876    Premium*  
            Scynexis Inc SCYX 10% Owner 2021-01-20 0 2021-01-22 1,800,000    Premium*  
            Landos Biopharma, Inc. LABP Director, 10% Owner 0 2021-02-09 17,960,839    Premium*  
            Astria Therapeutics, Inc ATXS Director 0 2024-02-01 6,485,420    Premium*  
            Prometheus Biosciences, Inc. RXDX 10% Owner 2021-03-16 0 2021-03-16 3,314,032    Premium*  
            Rain Therapeutics Inc. RAIN 10% Owner 2021-04-27 0 2021-10-12 2,487,019    Premium*  
            Nautilus Biotechnology, Inc NAUT 10% Owner 2021-05-24 497,038 2021-12-08 9,111,151    Premium*  
            Isoplexis Corp ISO 10% Owner 2021-10-12 0 2021-10-12 3,554,587    Premium*  
            Lianbio LIAN Director, 10% Owner 0 2024-02-15 57,575,533    Premium*  
            Acrivon Therapeutics, Inc. ACRV 10% Owner 0 2024-04-11 5,360,858    Premium*  
            Chembio Diagnostics Inc CEMI Former 10% Owner 2023-04-04 0 2023-04-27 0    Premium*  
            Soleno Therapeutics Inc SLNO 10% Owner 0 2023-06-06 2,207,753    Premium*  
            Cargo Therapeutics, Inc. CRGX Former 10% Owner 2023-11-14 0 2023-11-14 333,333    Premium*  
* Premium Members only  

Records found :    304         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 13
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ATHA Athira Pharma, Inc. Director   –       •       •   2023-12-27 4 B $2.28 $73,266 I/I 32,134 4,829,412 2.25 -
SLNO Soleno Therapeutics Inc 10% Owner   –       –       •   2023-05-25 4 B $5.18 $194,250 I/I 37,500 2,006,955 1.5 -
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2024-04-05 4 B $4.74 $178,755 I/I 37,712 9,275,851 1.5 %
LIAN Lianbio Director   –       •       •   2024-02-15 4 D $4.76 $182,955 I/I (38,436) 17,082 0 -
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-24 4 B $0.45 $17,778 I/I 39,506 5,029,040 1.5 %
ADMA ADMA Biologics Inc 10% Owner   –       –       •   2021-09-28 4 S $1.22 $49,536 I/I (40,603) 13,482,375 0 %
LIAN Lianbio Director   –       •       •   2022-05-24 4 B $2.47 $105,101 I/I 42,551 2,541,251 2.25 -
DOVA Dova Pharmaceuticals, Inc... 10% Owner   –       –       •   2019-07-11 4 B $16.67 $715,410 I/I 42,916 3,708,705 1.5 -
CERE Cerevel Therapeutics Hold... Director   –       •      –    2020-10-21 4 B $10.09 $435,838 I/I 43,195 157,295 2.1 %
CERE Cerevel Therapeutics Hold... Director   –       •      –    2021-08-23 4 B $25.78 $1,145,586 I/I 44,437 4,887,532 2.1 %
LJPC La Jolla Pharmaceutical C... 10% Owner   –       –       •   2018-02-15 4 B $32.42 $1,621,000 I/I 50,000 3,613,611 1.5 -
DOVA Dova Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-06-07 4 B $27.63 $1,409,154 I/I 50,000 3,081,151 1.5 -
MGTX Meiragtx Holdings Plc 10% Owner   –       –       •   2018-06-08 4 B $15.22 $761,000 I/I 50,000 3,370,065 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2018-09-21 4 B $12.53 $626,500 I/I 50,000 20,674,424 1.5 -
DOVA Dova Pharmaceuticals, Inc... 10% Owner   –       –       •   2019-07-05 4 B $16.46 $823,000 I/I 50,000 3,632,601 1.5 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2019-10-17 4 B $10.93 $546,500 I/I 50,000 10,852,467 1.5 -
CORI Corium International, Inc... 10% Owner   –       –       •   2018-01-16 4 B $11.83 $595,641 I/I 50,350 5,897,483 1.5 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2019-06-18 4 B $17.73 $899,656 I/I 50,742 9,776,764 1.5 -
VRCA Verrica Pharmaceuticals I... 10% Owner   –       –       •   2023-12-26 4 B $6.49 $354,691 I/I 54,652 6,777,566 1.5 %
CEMI Chembio Diagnostics Inc 10% Owner   –       –       •   2023-04-20 4 B $0.45 $25,200 I/I 56,000 4,919,334 1.5 %
ATNX Athenex, Inc. 10% Owner   –       –       •   2019-09-13 4 B $14.27 $805,056 I/I 56,416 10,705,245 1.5 -
CERE Cerevel Therapeutics Hold... Director   –       •      –    2021-08-25 4 B $28.57 $1,753,827 I/I 61,387 5,018,680 2.1 %
SLNO Soleno Therapeutics Inc 10% Owner   –       –       •   2023-06-02 4 B $5.93 $383,256 I/I 64,630 2,129,085 1.5 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2019-10-16 4 B $10.29 $691,714 I/I 67,222 10,802,467 1.5 -
CERE Cerevel Therapeutics Hold... Director   –       •      –    2021-08-26 4 B $30.23 $2,057,061 I/I 68,047 5,086,727 2.1 %
  304  Records found
  1   2   3   4  5   6   7   8   9   10   11   12   13      
  Page 4 of 13  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us